|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2001-7-20
|
|
pubmed:abstractText |
Recurrent herpes simplex labialis (HSL) occurs in 20% to 40% of the US population. Although the disease is self-limiting in persons with a healthy immune response, patients seek treatment because of the discomfort and visibility of a recurrent lesion.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0190-9622
|
|
pubmed:author |
pubmed-author:BarbarashR ARA,
pubmed-author:BerkJ AJA,
pubmed-author:Docosanol 10% Cream Study Group,
pubmed-author:GunnillL BLB,
pubmed-author:JonesT MTM,
pubmed-author:JorizzoJ LJL,
pubmed-author:KhalilM HMH,
pubmed-author:LAWSJ WJW,
pubmed-author:MikolichD JDJ,
pubmed-author:MorrowP RPR,
pubmed-author:RuoffG EGE,
pubmed-author:SacksS LSL,
pubmed-author:TARIAA,
pubmed-author:ThistedR ARA,
pubmed-author:YakatanG JGJ
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
45
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
222-30
|
|
pubmed:dateRevised |
2008-6-2
|
|
pubmed:meshHeading |
pubmed-meshheading:11464183-Acute Disease,
pubmed-meshheading:11464183-Administration, Topical,
pubmed-meshheading:11464183-Adolescent,
pubmed-meshheading:11464183-Adult,
pubmed-meshheading:11464183-Aged,
pubmed-meshheading:11464183-Aged, 80 and over,
pubmed-meshheading:11464183-Antiviral Agents,
pubmed-meshheading:11464183-Drug Administration Schedule,
pubmed-meshheading:11464183-Fatty Alcohols,
pubmed-meshheading:11464183-Female,
pubmed-meshheading:11464183-Herpes Labialis,
pubmed-meshheading:11464183-Humans,
pubmed-meshheading:11464183-Male,
pubmed-meshheading:11464183-Middle Aged,
pubmed-meshheading:11464183-Ointments,
pubmed-meshheading:11464183-Recurrence
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial.
|
|
pubmed:affiliation |
Viridae Clinical Sciences, Inc, and the University of British Columbia, Vancouver, Canada.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
